GlassScriptPhysician profile
Emmet Hunter Dyer
NPI 1962400903
$1,346.59
in general payments reported to CMS, 2019-2025
15 companies · $245 in 2025
The $245 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $129 · 2021: $172 · 2022: $461 · 2023: $273 · 2024: $66.06 · 2025: $245.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $584.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $583.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $218.84 | 2022-2023 | Sable |
| Cerapedics INC. | $199.83 | 2025 | I-Factor Peptide Enhanced Bone Graft |
| Nuvasive, INC. | $199.68 | 2022-2023 | Alif |
| Stryker Corporation | $171.71 | 2023 | Avs Anchor-L |
| Omniscient Neurotechnology America LTD | $150.00 | 2021 | |
| Medtronic, INC. | $103.82 | 2022-2025 | Midas Rex, Cd Horizon Spinal System, Aquamantys(Tm) |
| Spine Wave, INC. | $100.00 | 2022 | |
| Depuy Synthes Sales INC. | $56.73 | 2019 | |
| Medical Device Business Services, INC. | $39.20 | 2019 | |
| Aesculap, INC. | $23.64 | 2022 | |
| Heron Therapeutics, INC. | $23.43 | 2025 | Aponvie |
| Arbor Pharmaceuticals, INC. | $22.19 | 2021 | |
| Integra Lifesciences Corporation | $20.98 | 2019 | |
| Medtronic USA, INC. | $12.32 | 2019 | |
| Elevation Spine, INC. | $4.22 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Emmet Dyer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.